Yuki Sato

10PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPacific Peoples biomedical and clinical scienceMolecular targetsOther education not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 23, 2025
Perioperative Nivolumab in Resectable Non-Small Cell Lung Cancer: A Subanalysis of Japanese Patients From CheckMate 77T.

Fumihiro Tanaka, Yasutaka Watanabe, Shunichi Sugawara

|Oct 29, 2025
Cemiplimab in Japanese patients with advanced non-small cell lung cancer.

Yuki Sato, Yoko Tani, Hidenobu Ishii

|Apr 16, 2025
Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834.

Satoru Miura, Hiroshi Tanaka, Toshihiro Misumi

|Oct 19, 2024
Paraneoplastic neurological syndrome and its impact on the treatment outcomes of small-cell lung cancer: A single-center retrospective analysis.

Yuki Sato, Satoru Fujiwara, Chigusa Shirakawa

|Jun 26, 2024
Successful intracranial response of lorlatinib after resistance with alectinib and brigatinib in patients with ALK-positive lung adenocarcinoma: Implications of CNS penetration rate of brigatinib.

Yuki Sato, Yoshiharu Sato, Kei Irie

|Feb 03, 2022
Reply.

Jumpei Harada, Kazuma Nagata, Takeshi Morimoto

Pageof 2

Frequent Collaborators

2 joint publications

Jumpei Harada

2 joint publications

Kazuma Nagata

2 joint publications

Takeshi Morimoto

2 joint publications

Kentaro Iwata